Dynamic Modeling of the HCV Epidemic in IDU
注射吸毒者中 HCV 流行的动态建模
基本信息
- 批准号:7841910
- 负责人:
- 金额:$ 16.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-20 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcuteApplications GrantsAreaBiometryCaliforniaChronicCommunicable DiseasesDataDisease modelDoctor of PhilosophyDrug CompoundingDrug userEpidemicEpidemiologistEpidemiologyEquipmentGB virus CGoalsHIVHealth PolicyHepatitis CHepatitis C IncidenceHepatitis C virusInfectionInjecting drug userInternationalInterventionK-Series Research Career ProgramsMentored Research Scientist Development AwardMentorsModelingMono-SNeedle SharingPharmaceutical PreparationsPrevalenceProspective StudiesPublicationsResearchResearch DesignResearch InfrastructureResearch PersonnelResearch TrainingRoleSan FranciscoSolidStudy modelsTimeTrainingUniversitiesVaccinationbasebehavior changedisease transmissioneffective interventionepidemiologic dataexperiencemathematical modelmodel developmentmultidisciplinaryprofessorpublic health relevancetooltreatment strategytrendvaccine candidate
项目摘要
DESCRIPTION (provided by applicant): This is a K01 award application for Judith Hahn, Ph.D., an epidemiologist at the University of California, San Francisco. Her long-term goal is to become a leader in developing mathematical models to guide health policy for drug users that are informed by empirical studies designed especially for this purpose. She has had extensive experience studying HIV and HCV in drug users and has authored 40 publications, including 7 as first author. However, her role as co-investigator on multiple studies for small amounts (10-15%) of her time limits her ability to develop her own research area, and while she is trained in biostatistics and epidemiology, she has had no previous formal training in mathematical modeling. K01 support will allow her to become skilled in (1) mathematical modeling of infectious diseases and (2) the conduct of multidisciplinary studies of disease transmission, especially partner studies, to inform such models. She will be mentored by Dr. Wayne Getz, Professor at DC Berkeley, an international leader in disease modeling. She will be co mentored by Dr. Kimberly Page-Shafer, Associate Professor, UCSF, who specializes in multidisciplinary HCV and HIV prevention studies. While HCV infects the majority of injecting drug users (IDU), promising vaccine candidates are in development and models are needed to evaluate their potential impact. In Aim 1, Dr. Hahn will construct a mathematical model to predict HCV trends in IDU in San Francisco, in the absence of new or intensified interventions. In Aim 2, she will then model the effects of several interventions, such as vaccination, increased drug treatment, behavior change, and HGV treatment strategies on the predicted prevalence and incidence of HCV in IDU. In Aim 3, she will conduct a multidisciplinary prospective study of HCV serodiscordant injecting partnerships to compare the infectivity of acute HCV infection and HIV/HCV coinfection to chronic HCV mono-infection and to estimate HCV infectivity for use in the mathematical models. She will leverage data and infrastructure from several large studies to achieve these specific aims. This research will form the basis for a modeling study of HCV interventions in different geographic and injecting settings, including settings of high HIV prevalence, to be proposed in an R01 application before the end of the K award. Public Health Relevance: This training and research will equip Dr. Hahn with the tools to conduct modeling studies based on solid epidemiologic data to guide the planning of effective interventions to reduce the HCV epidemic in IDU.
描述(由申请人提供):这是加利福尼亚大学旧金山分校的流行病学家Judith Hahn博士的K01奖申请。她的长期目标是成为开发数学模型的领导者,以指导吸毒者的健康政策,这些政策是由尤其是为此目的设计的经验研究所告知的。她在吸毒者中研究了艾滋病毒和HCV的丰富经验,并撰写了40篇出版物,其中7个作为第一作者。但是,她作为少量时间(10-15%)的多项研究的共同研究角色限制了她发展自己的研究领域的能力,尽管她接受了生物统计学和流行病学的培训,但她以前没有在数学建模方面进行正式培训。 K01支持将使她能够熟练(1)传染病的数学建模,以及(2)对疾病传播(尤其是伴侣研究)进行多学科研究以告知此类模型的多学科研究。她将受到国际疾病建模国际领导人DC Berkeley教授Wayne Getz博士的指导。她将由UCSF副教授Kimberly Page-Shafer博士指导,他专门研究多学科HCV和HIV预防研究。尽管HCV感染大多数注射吸毒者(IDU),但有希望的候选疫苗正在开发中,需要模型来评估其潜在影响。在AIM 1中,Hahn博士将在没有新的或加强干预措施的情况下构建一个数学模型,以预测旧金山IDU的HCV趋势。在AIM 2中,她将建模多种干预措施的影响,例如疫苗接种,增加药物治疗,行为改变和HGV治疗策略对IDU HCV的预测患病率和发病率。在AIM 3中,她将对HCV SerioDiscordant进行多学科的前瞻性研究,以比较急性HCV感染和HIV/HCV共感染的感染性与慢性HCV单一感染的感染性,并估算用于在数学模型中使用的HCV感染性。她将利用几项大型研究的数据和基础架构来实现这些特定目标。这项研究将构成对不同地理和注射设置中HCV干预措施的建模研究的基础,包括高艾滋病毒患病率的设置,在k奖授予结束之前将在R01应用中提出。公共卫生相关性:这项培训和研究将使Hahn博士提供基于稳固流行病学数据进行建模研究的工具,以指导计划有效干预措施,以减少IDU中HCV流行病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUDITH ALISSA HAHN其他文献
JUDITH ALISSA HAHN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUDITH ALISSA HAHN', 18)}}的其他基金
Biomarkers for Alcohol/HIV Research (BAHR) Study
酒精/艾滋病毒研究生物标志物 (BAHR) 研究
- 批准号:
10615910 - 财政年份:2022
- 资助金额:
$ 16.74万 - 项目类别:
Biomarkers for Alcohol/HIV Research (BAHR) Study
酒精/艾滋病毒研究生物标志物 (BAHR) 研究
- 批准号:
10481535 - 财政年份:2022
- 资助金额:
$ 16.74万 - 项目类别:
The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
饮酒在艾滋病毒感染者结核感染和活动性结核病中的作用
- 批准号:
10303986 - 财政年份:2021
- 资助金额:
$ 16.74万 - 项目类别:
The Role of Alcohol Use in Incident TB Infection and Active TB Disease Among Persons Living with HIV
饮酒在艾滋病毒感染者结核感染和活动性结核病中的作用
- 批准号:
10683770 - 财政年份:2021
- 资助金额:
$ 16.74万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
9767523 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
10238903 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2)
减少饮酒并提高艾滋病毒/结核病合并感染饮酒者对结核病预防治疗依从性的干预措施(DIPT 1/2)
- 批准号:
9408285 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
Mobile technology to extend clinic-based counseling for HIV+s in Uganda
移动技术在乌干达扩大艾滋病毒临床咨询
- 批准号:
9906836 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
Training in Research Program on Alcohol Use by Persons with or at Risk for HIV
关于艾滋病毒感染者或高危人群饮酒研究计划的培训
- 批准号:
8603091 - 财政年份:2013
- 资助金额:
$ 16.74万 - 项目类别:
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV
艾滋病毒高危人群饮酒研究项目培训
- 批准号:
9918815 - 财政年份:2013
- 资助金额:
$ 16.74万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
An Intervention to Increase Retention in Care among HIV-Positive Black Men
提高艾滋病毒阳性黑人男性护理保留率的干预措施
- 批准号:
9978617 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
An Intervention to Increase Retention in Care among HIV-Positive Black Men
提高艾滋病毒阳性黑人男性护理保留率的干预措施
- 批准号:
9411626 - 财政年份:2017
- 资助金额:
$ 16.74万 - 项目类别:
Biomarkers of Drug-induced Kidney Injury in HIV
HIV 药物性肾损伤的生物标志物
- 批准号:
9351503 - 财政年份:2016
- 资助金额:
$ 16.74万 - 项目类别:
Biomarkers of Drug-induced Kidney Injury in HIV
HIV 药物性肾损伤的生物标志物
- 批准号:
9270400 - 财政年份:2016
- 资助金额:
$ 16.74万 - 项目类别: